Alzheimer's Drug ARIA Monitoring: Real-World Study Results
(MedPage Today) -- Rates of amyloid-related imaging abnormalities (ARIA) in Alzheimer's disease patients treated with lecanemab (Leqembi) in the real world were consistent with those seen in clinical trials, data from the LEADER study showed....
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.